You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Review: topical mupirocin or fusidic acid may be more effective than oral antibiotics for limited non-bullous impetigo

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: topical mupirocin or fusidic acid may be more effective than oral antibiotics for limited non-bullous impetigo

https://doi.org/10.1136/ebm.9.6.176

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Koning S, Verhagen AP, van Suijlekom-Smit LW, et al. Interventions for impetigo. Cochrane Database Syst Rev 2004;(2):CD003261.

    
 
 Q Which treatments are effective for impetigo?

    Clinical impact ratings Dermatology ★★★★★★☆ GP/FP/Primary care ★★★★★☆☆

    METHODS

    Embedded ImageData sources:

    Cochrane Skin Group Specialised Trials Register (March 2002), Cochrane Central Register of Controlled Trials (Issue 1, 2002), National Research Register (2002), Medline (1966 to January 2003), EMBASE/Excerpta Medica (1980 to March 2000), LILACS (November 2001), and metaRegister of Controlled Trials on the Current Controlled Trials website; hand searches of Yearbook of Dermatology (1938–66) and Yearbook of Drug Therapy (1949–66); reference lists; and contact with trial authors and pharmaceutical companies.

    Embedded ImageStudy selection and assessment:

    published and unpublished randomised controlled trials (RCTs) in any language that assessed any intervention for impetigo (non-bullous, bullous, secondary, and impetiginised dermatoses) in patients with diagnosed impetigo, preferably confirmed by bacterial culture; studies that assessed patients with broadly defined bacterial skin infections or pyoderma were included if results for patients with impetigo were reported separately. 2 independent reviewers assessed the methodological quality of individual trials.

    Embedded ImageOutcome:

    clinical cure …

    View Full Text

    Footnotes

    • For correspondence: Dr S Koning, Department of General Practice, Erasmus MC–University Medical Center Rotterdam, Rotterdam, The Netherlands. skoningerasmusmc.nl

    • Source of funding: not stated.